Cost-Cutting Plus Value-Add Defines Quality's Role in a Recession
CHAPEL HILL, N.C., April 23 /PRNewswire/ -- Pharmaceutical and biotech partners tasked with cutting costs and improving processes cross-functionally recently asked us:
What are the implications of the current economic situation on quality groups?
How can I harness the kn...
Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients
DEERFIELD, Ill. and SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Baxter
International Inc. and Halozyme Therapeutics, Inc. (Nasdaq: HALO ) today
announced the start of a Phase III clinical trial of Baxter's GAMMAGARD LIQUID
[Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the E...
Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
-Data Update Shows 71% of Evaluable Patients in the Trial's First Stage Achieved Objective Tumor Responses- -Patient Enrollment is Open in the Trial's Second Stage-
TUSTIN, Calif., Oct. 21 /PRNewswire-FirstCall/ -- Peregrine
Pharmaceuticals, Inc. (Nasdaq: PPHM ), a cli...
CardioWest™ Artificial Heart Approved For Highest Reimbursement in CMS History : Plus Up To $53,000 New Technology Add-on Payments
On July 31, the Centers for Medicare and Medicaid Services (CMS) issued its final decision to reimburse the CardioWest temporary Total Artificial Heart (TAH-t) through the highest paying Diagnostic Related Group codes, MS-DRG 001 and 002. In addition, CMS also approved the CardioWest artificial h...
Time Domain Showcases Precision Location Capability of Ultra Wideband PLUS Product Line at HIMSS 2008
UWB Gaining Ground in Healthcare Real-Time Location System (RTLS) Market
ORLANDO, Fla., Feb. 25 /PRNewswire/ -- Time Domain Corporation
( http://www.timedomain.com ), a leader in precision ultra wideband (UWB)
real- time location systems (RTLS), today demonstrated its Precision
Location Ultra ...
Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit
The first hemostasis kit combines two important surgical tools: Baxter's human thrombin and Pfizer's GELFOAM
DEERFIELD, Ill., Dec. 17 /PRNewswire-FirstCall/ -- Baxter Healthcare
Corporation today announced the Food and Drug Administration approval of
GlaxoSmithKline Announces Data on TYKERB(R) (Lapatinib) Plus Capecitabine for the Treatment of HER2 Positive Breast Cancer Brain Metastases
Study Shows TYKERB Combination Reduced the Size of Brain Tumors Associated with HER2-Positive Breast Cancer
SAN ANTONIO, Texas, Dec. 17 /PRNewswire/ -- GlaxoSmithKline announced
today results from the extension arm of a Phase II study on its
first-in-class, oral small molecul...
Roche Diagnostics Launches CoaguChek XS Plus System to Provide New PT/INR Point-of-Care Solution for Non-Waived Anticoagulation Services
FDA-Cleared, Next Generation Coagulation Monitor Offers Both Built-in Controls, and Optional External Liquid Quality Controls
INDIANAPOLIS, Oct. 29 /PRNewswire/ -- Roche Diagnostics' newly launched
CoaguChek XS Plus
System offers built-in controls and optional, external
PARI Respiratory's LC PLUS & PRONEB Ultra Deliver Dey, L.P.'s New COPD Therapy; Perforomist Launched Yesterday
MIDLOTHIAN, Va., Oct. 9 /PRNewswire/ -- PARI Respiratory Equipment's
breath-enhanced nebulizer, the PARI LC PLUS, and PRONEB Ultra compressor
deliver Dey, L.P.'s new COPD medication, Perforomist Inhalation Solution,
that launched nationwide yesterday. Dey, L.P. is a subsidiary of Mylan Inc.
Sunrise Biotech Holding Limited Application For Admission to PLUS
BEIJING, Nov. 14 /Xinhua-PRNewswire/ -- The directors of Sunrise Biotech
Holding Limited ("Sunrise" or the "Company"), a leading producer of organic
mulberry-based products in China, are pleased to announce the Company has
applied for the admission of its entire ordinary share capital for trad...
Physicians Plus to make alternative drug info available online
Madison, Wis. Physicians Plus
, an HMO in south-central Wisconsin with about 100,000 members, has purchased a web-based system from RxEOB , in Richmond, Virginia, to provide benefits information to consumers.
members will be able to access their personal pharmacy claims hist...
Determination of Acepromazine and its Major Metabolite in Equine Serum by LC-MS/MS using the Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer
Chromatography and Mass Spectrometry Application Report
Key Words Sensitivity Quantitation Finnigan LCQ Deca XP Plus
Equine serum Acepromazine
Gargi Choudhary, Thermo Electron Corporation, San Jose, CA USA
Wayne Skinner and Scott Stanley, Universi...
Fully Automated Nano-Electrospray Coupled with a Finnigan LCQ Deca XP Plus for Sub-fmol Proteomic Analysis
Dirk Chelius, Terry Zhang, and Ken Miller;
Thermo Electron Corporation, San Jose, CA
Key Words Sensitivity Proteomics Finnigan LCQ Deca XP Plus
PepFinder Kit Finnigan Surveyor HPLC LC/MS/MS
Detection limits of mass spectro...
Sensitivity and Quantitation using a Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer
Gargi Choudhary, Tania A. Sasaki, and Julian J. Phillips, Thermo Electron Corporation, San Jose, CA
Chromatography and Mass Spectrometry Application Report
Ion trap mass spectrometry is widely recognized for solving analytical problems requi...
Calcium Plus Assay Kit, Superior Detection for Specialized Targets
HIGHER MAXIMUM SIGNAL
COMPATIBLE WITH MORE TARGETS
SUITABLE FOR HTS APPLICATONS
The Calcium Plus
Assay Kit provides a reliable
and homogeneous method for detec...
Verifying Multichannel Pipettor Performance with Standard Dispense Solutions in the SpectraMax Plus (MaxLine Application Note #28)
Pipettors often fail to meet the manufacturers stated specifications 1- 5 and pipetting is a major source of laboratory error even when the pipettor is operating properly. Accuracy and precision specifications typically provided by pipettor manufacturer...
Using the SpectraMax Plus for USP Dissolution Calibration (MaxLine Application Note #27)
Calibration of a dissolution apparatus is necessary to produce accurate results for dissolution testing of pharmaceutical dosage forms and to allow comparison between batches and between laboratories. USP requirements for calibration are given in the Appa...
Microdetermination of Phosphorus Using the SpectraMax Plus Microplate Spectrophotometer: Choice of Microplate, Cuvette, or Test Tube Assay Formats (MaxLine Application Note #24)
Most spectrophotometric methods for inorganic phosphorus (Pi) analysis are based on the color formed upon the reduction of a phosphomolybdate complex. The classic (and still widely-used) method is that of Fiske and Subbarow 1 , in which the reduction is c...
PathCheck Applied to Measurement of Protein Solutions in the SpectraMax Plus Microplate Spectrophotometer (MaxLine Application Note #26)
Protein concentration is commonly estimated by measuring the absorbance at 280 nm and calculating the concentration using the extinction coefficient of the protein. The procedure is feasible because extinction coefficients are typically obtained using sta...
Benchmark Plus Microplate Reader: Quantitation of Protein Concentration Using Two Different Colorimetric Assay Kits, Rev A
Theresa Redila-Flores, Bio-Rad Laboratories, 2000 Alfred Nobel Drive,
Hercules, CA 94547 USA
The Bradford and Lowry assays are 2 colorimetric assays that are commonly
used to quantitate protein concentration. Bio-Rads protein assay (catalog
Cell Proliferation Assay Using the Benchmark Plus Microplate Spectrophotometer
William C Heiser, PhD and Ma Theresa Redila-Flores, Bio-Rad Laboratories,
Inc . , Hercules, CA 94547 USA
An accurate and rapid assessment of viable cell number and proliferation
is often required for in vitro and i...
Benchmark Plus Microplate Reader Scan Well Feature
Theresa Redila-Flores and Li Tian, PhD, Bio-Rad Laboratories, 2000 Alfred
Nobel Drive, Hercules, CA 94547 USA
The Benchmark Plus
microplate reader is a new monochromator- based absorbance
reader from Bio-Rad that offers superior convenience,...
Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A
Peter M Kilby, Roche Discovery Welwyn, 40 Broadwater Road, Welwyn
Garden City, Herts, AL7 3AY, UK. Current Address: Analytical Sciences,
Syngenta, Jealotts Hill International Research Centre, Bracknell, Berkshire,
RG42 6EY, UK
Novavax Reports Second Quarter 2009 Financial Results
...notes in April 2009 by paying 70% of the principal plus
accrued and unpaid interest, or $12.1 million, in ...s, the company elected to pay 50% of the principal plus
accrued and unpaid interest, or $2.6 million, in c...to pay the remaining $2.6 million of the principal plus
accrued and unpaid interest.
Entered into ...
InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
...ng q12h and q8h cohorts, respectively.
There was no evidence of viral rebound during ITMN-191 treatment in any cohort.
standard-of-care therapy was safe and generally well tolerated.
Also at the EASL meeting in late April, InterMune, Roche and Pharm...
OncoGenex Reports Second Quarter 2009 Financial Results
...pared to docetaxel alone. The median overall survival in patients
with advanced metastatic prostate cancer who were treated with OGX-011
docetaxel in a randomized phase 2 trial was 23.8 months compared
to 16.9 months for patients treated with docetaxel alone -- a 6.9
Pharmasset to Present at Canaccord Adams Conference
...nical-stage product candidates: RG7128, a nucleoside analog for chronic HCV infections, is in a Phase 2b clinical trial in combination with Pegasys(R) plus
Copegus(R) and is also in INFORM studies, the first series of studies designed to assess the potential of combinations of small molecules without Pega...
ETC Biomedical Announces Chamber Sale in India
...m. The BARA-MED(R) XD includes O.S.C.A.R. (TM) (Operating System for Control And Recordkeeping), giving you the benefit of patient comfort and safety, plus
electronic medical recordkeeping (EMR).
With O.S.C.A.R. (TM) on your team, you eliminate the need for operator dive time management and paper r...
Biotech Hot in July Driven by Positive Drug Data and Acquisitions
...gainst the inflammatory disease for over 50 years. Patients taking Benlysta plus
a standard treatment for one year had reduced symptoms - including pain, rashes and infections - compared with patients taking standard treatment plus
placebo. The study involved more than 860 patients in Asia, South America a...
PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants
...hene's common stock at a conversion price of $2.541667/share, which represents the closing price of the common stock on the NYSE Amex on July 24, 2009 plus
$0.041667. Principal and interest are due at maturity two years from the closing of the private placement.
In connection with the transaction...
Cardiogenesis Corporation Makes Pre-IDE Submission for PHOENIX Combination Delivery System
... CE MARK in 2006 and there have been over 50 clinical cases completed to date outside of the U.S.
"The early clinical results achieved with TMR plus
biologics suggest the potential of this combination therapy; to not only mitigate the debilitating effects of refractory angina, but potentially to im...
Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
EBITDA, which is defined as net income (loss) (excluding the non-controlling interest and income from equity method investees) plus
income taxes, interest expense, depreciation and amortization, was $299.1 million for the quarter ended June 30, 2009 and $625.8 million for the six m...
DNA Software, Inc. Awarded $2.5 M in NIH Funding to Develop Pioneering Nucleic Acid-based Technologies
...ion, and analysis of probes/primers, RT-PCR, qPCR, Multiplex PCR, Taqman, Beacons, Scorpions, Microarrays, SNP detection, FRET assays, RNAi, LATE-PCR, plus
new formats. OMP Developer EditionTM (OMP DE™) brings customizable, command line, high-throughput computing power to large assay design project...
Schering-Plough Reports Financial Results for 2009 Second Quarter
...ich include sales of the cholesterol joint venture plus
sales recorded by Schering-Plough in non-joint ven...ures
Adjusted net sales, defined as Net sales plus
an assumed 50 percent of
global cholesterol jo... NOTE: Adjusted net sales, defined as net sales plus
an assumed 50
percent of global cholesterol jo...
Environmental Tectonics Corporation Announces Promotion of Don R. Webber to VP of Sales for their BioMedical Division
... The BARA-MED((R)) XD includes O.S.C.A.R. (TM) (Operating System for Control And Recordkeeping), giving you the benefit of patient comfort and safety, plus
electronic medical recordkeeping (EMR).
With O.S.C.A.R. (TM) on your team, you eliminate the need for operator dive time management and paper...
Novavax Announces Repayment of $5 Million of Convertible Debt
...isfying certain conditions. Novavax has elected to pay 50% of the principal plus
accrued and unpaid interest in cash for a total payment of approximately $2...ion and issued common stock for the remaining $2.6 million of the principal plus
accrued and unpaid interest due by dividing that principal amount by $2.516...
DermTech and Stiefel Laboratories, Inc. to Further Evaluate EGIR(TM) Technology
...lif., July 15 /PRNewswire/ -- DermTech, Inc., a biotechnology company developing non-invasive molecular diagnostics for the early detection of disease plus
additional applications, announced that it has entered into the second part of a feasibility study using DermTech's advanced EGIR(TM) technology to he...
Oncolytics Biotech(R) Inc. Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting
... of these therapies in vitro. The combination index analyses revealed moderate to strong synergy in primary patient glioma cells treated with reovirus plus
IR and TMZ in vitro. This effect was also seen in vivo in flank tumor xenografts from primary patient tumors resistant to reovirus therapy alone.
Instrumentation Laboratory to Announce 'Passion & Results' Award Winners
...ort and energy and were chosen by the " IL eader Panel" to receive an award plus
a $2,000 educational grant for their institution in recognition of their 'p...elligent Quality Management (iQM(R)), GEM Premier(TM) 4000 analyzer, GEMweb plus
information management system, and the GEM PCL Plus, a portable coagulation...
Researchers unite to distribute quantum keys
...tribution, QKD, network).
Undertaken in late 2008, using the company internal glass fibre ring of Siemens and 4 of its dependencies across Vienna plus
a repeater station, near St. Plten in Lower Austria, the QKD demonstration involved secure telephone communication and video-conference as well as a r...